Quantcast

Latest pharmaceutical industry Stories

2014-10-17 12:29:40

DUBLIN, October 17, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/6cbkgn/latest_guidebook) has announced the addition of the "Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)" [http://www.researchandmarkets.com/research/6cbkgn/latest_guidebook ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769...

2014-10-17 08:26:00

Amgen Seeks Injunction Related to PCSK9 Inhibitor THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which...

2014-10-16 23:06:33

According to new report from BCC Research, the global market for nanoparticles in biotechnology and pharmaceuticals is expected to reach $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22% for the period 2014 to 2019. (PRWEB) October 16, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY, the global market for nanoparticles in biotechnology and pharmaceuticals is expected to...

2014-10-16 08:32:22

TORONTO, Oct. 16, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that it has completed its non-brokered private placement raising US$2,000,000 through issuance of 20 million common shares at US$0.10 each. The Company is debt free. The proceeds will be used for further development activities at its two subsidiaries BioHaven and Portage Pharma. The common shares issued are subject to...

2014-10-16 08:32:08

New Framework Provides More Predictable, Stable Environment for Payers and Manufacturers TORONTO, Oct. 16, 2014 /CNW/ - Canadians will save an estimated $3.8-billion through an unprecedented three-year agreement reached between Canada's provinces and territories and the generic pharmaceutical industry, Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), said today. "This national framework provides enormous additional savings to Canada's health-care...

2014-10-16 08:31:22

DUBLIN, Oct. 16, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR(®), which is a central nervous system stimulant indicated for the treatment of Attention Deficit...

2014-10-16 08:30:45

Patent estate includes thirteen issued U.S. patents, thirty patents worldwide REDWOOD CITY, Calif., Oct. 16, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update regarding its growing patent estate which totals 30 issued patents worldwide. These issued patents cover AcelRx's sufentanil...

2014-10-15 16:24:09

Minneapolis, MN, Oct. 15, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the third quarter 2014 on Thursday, November 6, 2014. BioAmber will also hold a live investor conference call and webcast at 4:30 PM Eastern Time (1:30 PM PT) to discuss the results. Conference Call and Webcast Thursday, November 6, 2014 @ 4:30 PM Eastern Time /1:30 PM...

2014-10-15 12:32:38

ST. PETERSBURG, Russia, October 15, 2014 /PRNewswire/ -- Russian pharmaceutical companies are actively squeezing out foreign therapeutic manufacturers from the government tenders. The atients' support state program allocates the highest budget for rituximab, a drug used in the treatment of hematological cancers. In 2013, 217 million dollars were appropriated from the federal budget for this drug alone. This year, for the first time, Russian biosimilar drug AcellBia will be...

2014-10-15 12:32:31

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. This report provides:An overview of the global market for ADCs as a part of the pharmaceutical industry that is looking for innovative technologies.Analyses of global market trends, with data from 2012, 2013, and projections of compound annual...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin